Sexual health
PT-141
Melanocortin-receptor agonist that works on desire in the brain, not blood flow in the pelvis. FDA-approved as Vyleesi for premenopausal HSDD.
€84.99per vial
Choose an option
1
- Pay with Bitcoin
- Discreet shipping within Germany
- Purity-guaranteed batches
- 14-day refund period if unsatisfied
Delivery & guarantee
Orders typically arrive within 3 weeks.
If your delivery arrives late, you'll receive a discount on your next order.
About
PT-141 (bremelanotide) is the rare peptide on this site with a regulatory approval behind it. The FDA cleared it in 2019 as Vyleesi for hypoactive sexual desire disorder in premenopausal women.
Read the full research guideWhy people choose it
- Drives sexual desire centrally, useful when PDE5 inhibitors have stopped working or were never the right tool
- Works in both sexes. The female HSDD indication is the licensed one, male use is off-label but widely practised
- Onset 30 to 45 minutes, effect lasts several hours, no daily build-up required
- Single-shot usability. You don't need to be on it continuously to feel the effect
At a glance
- Experience level
- Intermediate
- Administration
- Subcutaneous
Sold for laboratory research only. Not for human consumption. No therapeutic claims are made.
Sign in to view this product
PT-141
Log in or create a free account to see full details and prices.
Don't have an account? Sign up